Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

Silk Road Medical Q2 EPS $(0.42) Misses $(0.38) Estimate, Sales $51.24M Beat $49.60M Estimate

Author: Benzinga Newsdesk | August 07, 2024 05:12pm
Silk Road Medical (NASDAQ:SILK) reported quarterly losses of $(0.42) per share which missed the analyst consensus estimate of $(0.38) by 10.53 percent. This is a 20 percent decrease over losses of $(0.35) per share from the same period last year. The company reported quarterly sales of $51.24 million which beat the analyst consensus estimate of $49.60 million by 3.31 percent. This is a 13.12 percent increase over sales of $45.30 million the same period last year.

Posted In: SILK


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist